Search results for: “FDA Approval”
-
Mercia Asset Management invests into Locate Bio
•
LONDON, UK: Mercia Asset Management announced a significant syndicated investment into existing direct investment portfolio company Locate Bio…
-
Venture Life Group has acquired BBI Healthcare Limited for £36 million
•
LONDON, UK: Venture Life Group has acquired BBI Healthcare Limited, a global market leading Women’s Health and Energy…
-
Avacta signs collaboration agreement with Bruker
•
LONDON: Avacta Group plc has entered into a collaboration agreement with Bruker Corporation to evaluate the Affimer-based, bead…
-
Sumitovant Biopharma will acquire Urovant Sciences for $584 million
•
IRVINE: Urovant Sciences has entered into a definitive agreement in which Sumitovant Biopharma will acquire Urovant Sciences for…
-
PureTech Health
•
PureTech Health is a biotechnology company which develops medicines to combat serious diseases. It is listed on the…
-
Sunshine State Tea begins roll out of CBD & Vitamin infused teas
•
VANCOUVER: Redfund Capital Corp. announced that its portfolio client Sunshine State Tea will begin manufacturing its lineup of…
-
Graph Blockchain applauds Datametrex for their response to Covid-19 pandemic
•
TORONTO: Graph Blockchain Inc. applauds Datametrex Limited for securing the rights to import COVID-19 detection kit into Canada…
-
Dechra Pharmaceuticals acquires Ampharmco LLC for $30mn
•
LONDON, UK: The Board of Dechra Pharmaceuticals has announced the acquisition of Ampharmco LLC (APC) and its associated…
-
Onego Bio secures EUR 14 million in new funding from European Innovation Council
•
LONDON: Onego Bio Ltd, an Agronomics company, has secured EUR 14 million in new funding from the European…
-
AOTI Inc. commences trading on London Stock Exchange
•
AOTI has all of the building blocks in place to secure expanded market access and commercialisation of our…
-
genedrive plc announces multi-tiered shares sale
•
MANCHESTER, UK: genedrive plc (LSE: GDR), a leader in point-of-care pharmacogenetic testing, has unveiled a comprehensive fundraising initiative…
-
Poolbeg Pharma signs option agreement to acquire orphan drug candidate
•
LONDON, UK: Poolbeg Pharma (AIM: POLB) has entered into an exclusive 12-month option agreement with Silk Road Therapeutics…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.